Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma
Identifieur interne : 003B50 ( Main/Exploration ); précédent : 003B49; suivant : 003B51Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma
Auteurs : W. Frederick Sample [États-Unis] ; Harold R. Gertner [États-Unis] ; Paul B. Chretien [États-Unis]Source :
- Journal of the National Cancer Institute [ 0027-8874 ] ; 1971.
Abstract
The in vitro reactivity in autologous serum of lymphocytes from 100 normal persons and 120 cancer patients was determined by quantitation of phytohemagglutinin-induced tritiated thymidine incorporation. With the data from the study of normal lymphocytes, an age-correlated range of normal lymphocyte reactivity in autologous serum was derived. With this used as the criterion, the sera of 9 patients with carcinoma, whose lymphocytes in autologous serum had markedly low reactivity, were isolated and assayed for a suppressive effect on normal lymphocyte reactivity. A pool of AB sera, in which the reactivity of normal lymphocytes did not differ from their reactivity in autologous serum, was used as a constant homologous reference serum. The reactivity of normal lymphocytes in serum from each of the 9 cancer patients was lower than their reactivity in the homologous pooled AB serum. The data demonstrate an inhibitor of normal lymphocyte reactivity in the sera of patients with carcinoma.
Url:
DOI: 10.1093/jnci/46.6.1291
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002A23
- to stream Istex, to step Curation: 002A23
- to stream Istex, to step Checkpoint: 002890
- to stream Main, to step Merge: 003C30
- to stream Main, to step Curation: 003B50
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma</title>
<author><name sortKey="Sample, W Frederick" sort="Sample, W Frederick" uniqKey="Sample W" first="W. Frederick" last="Sample">W. Frederick Sample</name>
</author>
<author><name sortKey="Gertner, Harold R" sort="Gertner, Harold R" uniqKey="Gertner H" first="Harold R." last="Gertner">Harold R. Gertner</name>
</author>
<author><name sortKey="Chretien, Paul B" sort="Chretien, Paul B" uniqKey="Chretien P" first="Paul B." last="Chretien">Paul B. Chretien</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5ADC6269F4C423CBA0285413ECEFEA762957CB1B</idno>
<date when="1971" year="1971">1971</date>
<idno type="doi">10.1093/jnci/46.6.1291</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-PZW7NRH9-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A23</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002A23</idno>
<idno type="wicri:Area/Istex/Curation">002A23</idno>
<idno type="wicri:Area/Istex/Checkpoint">002890</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002890</idno>
<idno type="wicri:doubleKey">0027-8874:1971:Sample W:inhibition:of:phytohemagglutinin</idno>
<idno type="wicri:Area/Main/Merge">003C30</idno>
<idno type="wicri:Area/Main/Curation">003B50</idno>
<idno type="wicri:Area/Main/Exploration">003B50</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Inhibition of Phytohemagglutinin-Induced <hi rend="italic">In Vitro</hi>
Lymphocyte Transformation by Serum From Patients With Carcinoma</title>
<author><name sortKey="Sample, W Frederick" sort="Sample, W Frederick" uniqKey="Sample W" first="W. Frederick" last="Sample">W. Frederick Sample</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Surgery Branch, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Gertner, Harold R" sort="Gertner, Harold R" uniqKey="Gertner H" first="Harold R." last="Gertner">Harold R. Gertner</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Surgery Branch, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Chretien, Paul B" sort="Chretien, Paul B" uniqKey="Chretien P" first="Paul B." last="Chretien">Paul B. Chretien</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Surgery Branch, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of the National Cancer Institute</title>
<title level="j" type="abbrev">Journal of the National Cancer Institute</title>
<idno type="ISSN">0027-8874</idno>
<idno type="eISSN">1460-2105</idno>
<imprint><publisher>Oxford University Press</publisher>
<date when="1971-06">1971</date>
<biblScope unit="vol">46</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1291">1291</biblScope>
<biblScope unit="page" to="1297">1297</biblScope>
</imprint>
<idno type="ISSN">0027-8874</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0027-8874</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">The in vitro reactivity in autologous serum of lymphocytes from 100 normal persons and 120 cancer patients was determined by quantitation of phytohemagglutinin-induced tritiated thymidine incorporation. With the data from the study of normal lymphocytes, an age-correlated range of normal lymphocyte reactivity in autologous serum was derived. With this used as the criterion, the sera of 9 patients with carcinoma, whose lymphocytes in autologous serum had markedly low reactivity, were isolated and assayed for a suppressive effect on normal lymphocyte reactivity. A pool of AB sera, in which the reactivity of normal lymphocytes did not differ from their reactivity in autologous serum, was used as a constant homologous reference serum. The reactivity of normal lymphocytes in serum from each of the 9 cancer patients was lower than their reactivity in the homologous pooled AB serum. The data demonstrate an inhibitor of normal lymphocyte reactivity in the sera of patients with carcinoma.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Sample, W Frederick" sort="Sample, W Frederick" uniqKey="Sample W" first="W. Frederick" last="Sample">W. Frederick Sample</name>
</region>
<name sortKey="Chretien, Paul B" sort="Chretien, Paul B" uniqKey="Chretien P" first="Paul B." last="Chretien">Paul B. Chretien</name>
<name sortKey="Gertner, Harold R" sort="Gertner, Harold R" uniqKey="Gertner H" first="Harold R." last="Gertner">Harold R. Gertner</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B50 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B50 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:5ADC6269F4C423CBA0285413ECEFEA762957CB1B |texte= Inhibition of Phytohemagglutinin-Induced In Vitro Lymphocyte Transformation by Serum From Patients With Carcinoma }}
This area was generated with Dilib version V0.6.33. |